Valuations
’ disease, Death
For the evaluation of patients in this trial, the baseline was defined as the last observation before the administration of fenofibrate on day 0. The patients’ disease severity was assessed on an ordinal scale according to the following categories: The scale is as follows: (1) Death; (2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); (3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; (4) Hospitalized, requiring supplemental oxygen; (5) Hospitalized, not requiring supplemental oxygen; (6) Not hospitalized, limitation of activities; (7) Not hospitalized, no limitations of activities. Clinical status was recorded at baseline and every day during hospitalization.